Pharmaceutical Preparations · DE · CIK 1880438
AN2 Therapeutics discovers and develops novel small-molecule therapeutics using boron chemistry for various diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 3, 2026: 5 sold $50K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Williams Sarah JoannePrincipal Accounting Officer | Sell | 327 | $1.06 | $347 |
| Jan 6, 2026 | Eizen Joshua MSee Remarks | Sell | 6,931 | $1.01 | $7K |
| Jan 6, 2026 | Chanda SanjayChief Development Officer | Sell | 5,956 | $1.01 | $6K |
| Jan 6, 2026 | Day LucyChief Financial Officer | Sell | 5,512 | $1.01 | $6K |
| Jan 6, 2026 | Prior Stephen DavidChief Strategy Officer | Sell | 2,858 | $1.01 | $3K |
| Jan 5, 2026 | Eizen Joshua MSee Remarks | Sell | 17,923 | $1.00 | $18K |
| Jan 5, 2026 | Prior Stephen DavidChief Strategy Officer | Sell | 3,604 | $1.00 | $4K |
| Jan 5, 2026 | Chanda SanjayChief Development Officer | Sell | 3,295 | $1.00 | $3K |
| Jan 5, 2026 | Day LucyChief Financial Officer | Sell | 3,295 | $1.00 | $3K |
| Nov 4, 2025 | Eizen Joshua MSee Remarks | Sell | 2,819 | $1.14 | $3K |
| Nov 4, 2025 | Prior Stephen DavidChief Strategy Officer | Sell | 765 | $1.14 | $872 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.